Small cell lung cancer is a type of neuroendocrine tumor (NET). Learn more about the different NETs, including how risk factors, diagnosis, and treatment differ.

A neuroendocrine tumor (NET) is a slow-growing type of cancer that begins in your hormone-producing cells. It is rare, but doctors diagnose more cases each year. An estimated 170,000 Americans ...

Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer cases. Only 2,000 to 4,500 are diagnosed in the U.S. each year.

Neuroendocrine tumors can occur anywhere in your body but usually grow in your lungs or digestive tract. Our specialists decide on treatment strategies based on the tumor’s location, pathology, and ...

Pulmonary high-grade neuroendocrine carcinomas (HGNECs) are a distinct type of lung cancer that includes small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC). SCLC and LCNEC ...

News Release 17-Oct-2023 Lung, kidney, and neuroendocrine tumor cancer studies led by Dana-Farber presented at ESMO Congress 2023 Reports and Proceedings Dana-Farber Cancer Institute ...

Researchers at Boston Medical Center and Dana-Farber Cancer Institute conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single cell resolution, unlocking new insights ...

In the cohort of 95 patients with pancreatic neuroendocrine tumors, the median progression-free survival with cabozantinib was 13.8 months, as compared with 4.4 months with placebo (stratified ...

Nonrandomized trials have also demonstrated that FOLFOX/CAPOX can offer tumor response in approximately 30% of patients with G1-2 PanNENs, with a median PFS in the range of 12 months, including those ...